                         SEQUENCE LISTING

<110>  SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
       Hongbo, PANG
       Erkki, RUOSLAHTI
 
<120>  TUMOR ASSOCIATED MONOCYTE/MACROPHAGE BINDING PEPTIDE AND METHODS 
       OF USE THEREOF

<130>  SBMRI 17-012 PCT

<150>  62/500,224
<151>  2017-05-02

<160>  19    

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  1

Cys Arg Val Leu Arg Ser Gly Ser Cys 
1               5                   


<210>  2
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  2

Arg Val Leu Arg Ser Gly Ser 
1               5           


<210>  3
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  D-form amino acids

<400>  3

Lys Leu Ala Lys Leu Ala Lys Lys Leu Ala Lys Leu Ala Lys 
1               5                   10                  


<210>  4
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  4

Arg Pro Ala Arg Pro Ala Arg 
1               5           


<210>  5
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  5

Lys Leu Ala Lys Lys Leu Ala Lys Leu Ala Lys Lys Leu Ala 
1               5                   10                  


<210>  6
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Pepetide

<400>  6

Lys Ala Ala Lys Lys Ala Ala Lys Ala Ala Lys Lys Ala Ala 
1               5                   10                  


<210>  7
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  7

Lys Leu Gly Lys Lys Leu Gly Lys Leu Gly Lys Lys Leu Gly Lys Leu 
1               5                   10                  15      


Gly Lys Lys Leu Gly 
            20      


<210>  8
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  8

Ala Arg Ala Leu Pro Ser Gln Arg Ser Arg 
1               5                   10  


<210>  9
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  9

Gly Gly Ser Gly Gly Ser Lys Gly 
1               5               


<210>  10
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  10

Gly Gly Arg Val Leu Arg Ser 
1               5           


<210>  11
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  11

Ser Val Ala Tyr Asp 
1               5   


<210>  12
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  12

Arg Ser Gly Leu Arg Ser Ser 
1               5           


<210>  13
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  13

Gly Arg Leu Leu Arg Ser Gly 
1               5           


<210>  14
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  14

Gly Arg Met Leu Arg Ser Gly 
1               5           


<210>  15
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  15

Gly Gly Ala Ser Ile Thr 
1               5       


<210>  16
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  16

Ser Val Gly Arg Ser Met Arg Ser 
1               5               


<210>  17
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  17

Gly Arg Val Leu Arg Ser Ser 
1               5           


<210>  18
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  18

Cys Gly Asn Lys Arg Thr Arg Gly Cys 
1               5                   


<210>  19
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(22)
<223>  Xaa is any amino acid

<400>  19

Arg Val Leu Arg Ser Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Xaa 
            20          


